H1N1 Vaccine Makers Get New Virus Strains In Hopes Of Increasing Yield
This article was originally published in The Pink Sheet Daily
Executive Summary
Adequate supply of the vaccine is key to FDA's determination of whether to approve adjuvanted H1N1 vaccines.
You may also be interested in...
H1N1 Vaccine Will Be Free For Medicare Part B Enrollees
CMS says it plans to cover the H1N1 vaccine for Medicare Part B beneficiaries on top of normal seasonal flu vaccines
H1N1 Vaccine Will Be Free For Medicare Part B Enrollees
CMS says it plans to cover the H1N1 vaccine for Medicare Part B beneficiaries on top of normal seasonal flu vaccines
H1N1 Vaccine Trials: NIH Will Mix And Match Antigens, Adjuvants
The National Institutes of Health is developing a plan B as H1N1 vaccine manufacturers race to produce enough product by the start of flu season. The agency is going to mix and match antigen and adjuvant from different sponsors to try to find the best immunogenicity